CDI(CODX) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results SALT LAKE CITY, August 8, 2024— Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended June 30, 2024. Second Quarter 2024 Financial Results: ● Revenue of $2.7 million, up from$0.2 million during the prior year primarily due to the achievement of certain milestones under variou ...